Homarylamine
Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is a substituted phenethylamine. It is the N-methylated analog of MDPEA. Homoarylamine was patented as an antitussive in 1956,[2] but has never been used medically as such.
Clinical data | |
---|---|
Other names | 1,3-benzodioxolyl-N-methyl-5-ethanamine; 3,4-methylenedioxy-N-methyl-2-phenylethylamine; Norlobivine |
Routes of administration | Various |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13NO2 |
Molar mass | 179.219 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Reactions
Reaction of homoarylamine with formaldehyde gives hydrastinine.
See also
- Hydrastine, an alkaloid derivative of homarylamine
References
- "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
- U.S. Patent 2,820,739
Phenylalkyl- amines (other than cathinones) |
|
---|---|
Cyclized phenyl- alkylamines | |
Cathinones | |
Tryptamines | |
Chemical classes |
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.